{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:13Z","timestamp":1787070973014,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Hepatosplenic T-cell lymphoma (HSTCL) is a rare fatal T-cell neoplasm with unique clinical and laboratory features. There is, however, significant morphological and immunophenotypic heterogeneity which may lead to diagnostic dilemma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims and Objectives:<\/jats:title>\n                    <jats:p>The study was aimed to study the prevalence and clinic-pathological spectrum of this rare variant of T cell lymphoma in the Indian subcontinent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis of all consecutive cases of HSTCL diagnosed over a period of 6 years was carried out. The clinical and laboratory parameters of all these patient were reviewed and analysed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 12 cases of HSTCL were diagnosed during this period which accounted for 1.76% of all non-Hodgkin's lymphomas (NHLs) and 9.1% of all T-cell NHLs. The median (range) age of presentation was 23 (16\u201330) years. Leukocytosis, peripheral blood (PB) involvement, and a blastic morphology were noted in 41%, 67%, and 58% of the cases, respectively. FCI proved these cells to have a mature, dual-negative (CD4\u2212\/CD8\u2212) T-cell phenotype with a gamma\u2013delta T-cell receptor restriction. Frequent loss of CD5 expression (84%) was also noted. These patients invariably had a fatal outcome and majority died within a year of diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The incidence of leukocytosis and a blastoid morphology is quite frequent in HSTCL. Hence, a differential diagnosis of HSTCL should always be considered in young patients presenting with splenomegaly and exhibiting atypical lymphoid\/blastoid cells in the PB or a marrow. An FCI can readily diagnose and differentiate them from an acute lymphoblastic leukemia\/lymphoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_877_19","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T12:03:16Z","timestamp":1634904196000},"page":"1093-1097","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Hepatosplenic T-cell lymphoma diagnosed using flow cytometry. A single-center study of 12 cases from North India"],"prefix":"10.4103","volume":"18","author":[{"given":"Khaliqur","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soniya","family":"Nityanand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-33-20241021","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood-2003-05-1675","article-title":"Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome: Report on a series of 21 patients","volume":"102","author":"Belhadj","year":"2003","journal-title":"Blood"},{"key":"R2-33-20241021","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1002\/ajh.24711","article-title":"Incidence, clinical findings, and survival of hepatosplenic T-cell lymphoma in the United States","volume":"92","author":"Durani","year":"2017","journal-title":"Am J Hematol"},{"key":"R3-33-20241021","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: Pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"R4-33-20241021","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/annonc\/mdn751","article-title":"Hepatosplenic gamma-delta T-cell lymphoma: Clinicopathological features and treatment","volume":"20","author":"Falchook","year":"2009","journal-title":"Ann Oncol"},{"key":"R5-33-20241021","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/10428194.2011.622421","article-title":"Clinicopathological features of hepatosplenic T cell lymphoma: A single centre experience from India","volume":"53","author":"Patkar","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R6-33-20241021","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clml.2013.03.011","article-title":"Hepatosplenic \u03b3\u03b4 T-cell lymphoma: An overview","volume":"13","author":"Visnyei","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R7-33-20241021","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJM198103123041106","article-title":"Erythrophagocytic T\u03b3 lymphoma","volume":"304","author":"Kadin","year":"1981","journal-title":"New Engl J Med"},{"key":"R8-33-20241021","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood.V75.11.2213.2213","article-title":"Hepatosplenic T-cell lymphoma: Sinusal\/sinusoidal localization of malignant cells expressing the T-cell receptor \u03b3\u03b4","volume":"75","author":"Farcet","year":"1990","journal-title":"Blood"},{"key":"R9-33-20241021","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","article-title":"Hepatosplenic T-cell lymphoma and inflammatory bowel disease","volume":"4","author":"Thai","year":"2010","journal-title":"J Crohns Colitis"},{"key":"R10-33-20241021","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenicalphabeta T-cell lymphomas: A report of 14 cases and comparison with hepatosplenic gamma delta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R11-33-20241021","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.humpath.2011.01.034","article-title":"Hepatosplenic T-cell lymphoma: Clinicopathologic, immunophenotypic, and molecular characterization of 17 Chinese cases","volume":"42","author":"Lu","year":"2011","journal-title":"Hum Pathol"},{"key":"R12-33-20241021","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/sj.leu.2401784","article-title":"Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990","volume":"14","author":"Weidmann","year":"2000","journal-title":"Leukemia"},{"key":"R13-33-20241021","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/PAS.0000000000000614","article-title":"Prognostic factors of hepatosplenicT-cell lymphoma (HSTCL): A clinicopathologic, immunophenotypic, and cytogenetic analysis of 28 patients","volume":"40","author":"Yabe","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R14-33-20241021","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R15-33-20241021","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/IJPM.IJPM_442_17","article-title":"Expect the unexpected \u2013 Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener","volume":"61","author":"Chauhan","year":"2018","journal-title":"Indian J Pathol Microbiol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_877_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:49Z","timestamp":1787067589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_877_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_877_19","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}